cell lines ls174t atcc cat Search Results


atcc dld1  (CLS Cell Lines Service GmbH)
93
CLS Cell Lines Service GmbH atcc dld1
Atcc Dld1, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+ls174t+atcc+cat/DLD-1+Cells/pmc07752919__41467_2020_20222_MOESM7_ESM-30-8-10
Average 93 stars, based on 1 article reviews
atcc dld1 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
ls 174t  (ATCC)
97
ATCC ls 174t
Ls 174t, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+ls174t+atcc+cat/LS+174T/pmc11481099-109-28-33
Average 97 stars, based on 1 article reviews
ls 174t - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier
atcc dld1  (ATCC)
99
ATCC atcc dld1
Atcc Dld1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+ls174t+atcc+cat/DLD-1/pmc07752919__41467_2020_20222_MOESM7_ESM-30-8-8
Average 99 stars, based on 1 article reviews
atcc dld1 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
human crc cell lines  (ATCC)
99
ATCC human crc cell lines
Different CSE1L expression levels in the colon cell lines. (A) Relative mRNA expression levels of CSE1L in CCD-18Co and FHC cells. (B) Relative mRNA expression levels of CSE1L in the <t>CRC</t> cell lines. (C) Relative mRNA expression levels of CSE1L in overconfluent Caco-2 cells. (D) Relative mRNA expression levels of c-Myc in overconfluent Caco-2 cells. (E) Protein expression level of CSE1L and c-Myc in overconfluent Caco-2 cells. (F) Relative mRNA expression levels of CSE1L in HCT116 cells with or <t>without</t> <t>p53</t> expression. (G) Protein expression level of CSE1L in HCT116 cells with or without p53 expression. (H) Knockdown efficacy of p53 by mRNA level in HCT116 p53 +/+ cells. (I) Relative mRNA expression levels of CSE1L in HCT116 cells without or with p53 knockdown. (J) Protein expression levels of CSE1L in 5-FU-treated wild-type HCT116 cells. * P<0.05, ** P<0.01 and *** P<0.001. CRC, colorectal cancer; 5-FU, 5-fluouracil; shLuc, lentiviral construct targeting luciferase; shp53, lentiviral construct targeting p53; wt, wild-type; sh, short hairpin; CSE1L, chromo-some segregation 1-like protein.
Human Crc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+ls174t+atcc+cat/HCT+116/pmc09084551-55-3-25
Average 99 stars, based on 1 article reviews
human crc cell lines - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
ls174t  (CLS Cell Lines Service GmbH)
90
CLS Cell Lines Service GmbH ls174t
Different CSE1L expression levels in the colon cell lines. (A) Relative mRNA expression levels of CSE1L in CCD-18Co and FHC cells. (B) Relative mRNA expression levels of CSE1L in the <t>CRC</t> cell lines. (C) Relative mRNA expression levels of CSE1L in overconfluent Caco-2 cells. (D) Relative mRNA expression levels of c-Myc in overconfluent Caco-2 cells. (E) Protein expression level of CSE1L and c-Myc in overconfluent Caco-2 cells. (F) Relative mRNA expression levels of CSE1L in HCT116 cells with or <t>without</t> <t>p53</t> expression. (G) Protein expression level of CSE1L in HCT116 cells with or without p53 expression. (H) Knockdown efficacy of p53 by mRNA level in HCT116 p53 +/+ cells. (I) Relative mRNA expression levels of CSE1L in HCT116 cells without or with p53 knockdown. (J) Protein expression levels of CSE1L in 5-FU-treated wild-type HCT116 cells. * P<0.05, ** P<0.01 and *** P<0.001. CRC, colorectal cancer; 5-FU, 5-fluouracil; shLuc, lentiviral construct targeting luciferase; shp53, lentiviral construct targeting p53; wt, wild-type; sh, short hairpin; CSE1L, chromo-some segregation 1-like protein.
Ls174t, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+ls174t+atcc+cat/LS174T+Cells/pm32080340-34-39-40
Average 90 stars, based on 1 article reviews
ls174t - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
188 panc 1 atcc cat  (ATCC)
99
ATCC 188 panc 1 atcc cat
Different CSE1L expression levels in the colon cell lines. (A) Relative mRNA expression levels of CSE1L in CCD-18Co and FHC cells. (B) Relative mRNA expression levels of CSE1L in the <t>CRC</t> cell lines. (C) Relative mRNA expression levels of CSE1L in overconfluent Caco-2 cells. (D) Relative mRNA expression levels of c-Myc in overconfluent Caco-2 cells. (E) Protein expression level of CSE1L and c-Myc in overconfluent Caco-2 cells. (F) Relative mRNA expression levels of CSE1L in HCT116 cells with or <t>without</t> <t>p53</t> expression. (G) Protein expression level of CSE1L in HCT116 cells with or without p53 expression. (H) Knockdown efficacy of p53 by mRNA level in HCT116 p53 +/+ cells. (I) Relative mRNA expression levels of CSE1L in HCT116 cells without or with p53 knockdown. (J) Protein expression levels of CSE1L in 5-FU-treated wild-type HCT116 cells. * P<0.05, ** P<0.01 and *** P<0.001. CRC, colorectal cancer; 5-FU, 5-fluouracil; shLuc, lentiviral construct targeting luciferase; shp53, lentiviral construct targeting p53; wt, wild-type; sh, short hairpin; CSE1L, chromo-some segregation 1-like protein.
188 Panc 1 Atcc Cat, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+lines+ls174t+atcc+cat/PANC-1/pm41579861-281-10-12
Average 99 stars, based on 1 article reviews
188 panc 1 atcc cat - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

Image Search Results


Different CSE1L expression levels in the colon cell lines. (A) Relative mRNA expression levels of CSE1L in CCD-18Co and FHC cells. (B) Relative mRNA expression levels of CSE1L in the CRC cell lines. (C) Relative mRNA expression levels of CSE1L in overconfluent Caco-2 cells. (D) Relative mRNA expression levels of c-Myc in overconfluent Caco-2 cells. (E) Protein expression level of CSE1L and c-Myc in overconfluent Caco-2 cells. (F) Relative mRNA expression levels of CSE1L in HCT116 cells with or without p53 expression. (G) Protein expression level of CSE1L in HCT116 cells with or without p53 expression. (H) Knockdown efficacy of p53 by mRNA level in HCT116 p53 +/+ cells. (I) Relative mRNA expression levels of CSE1L in HCT116 cells without or with p53 knockdown. (J) Protein expression levels of CSE1L in 5-FU-treated wild-type HCT116 cells. * P<0.05, ** P<0.01 and *** P<0.001. CRC, colorectal cancer; 5-FU, 5-fluouracil; shLuc, lentiviral construct targeting luciferase; shp53, lentiviral construct targeting p53; wt, wild-type; sh, short hairpin; CSE1L, chromo-some segregation 1-like protein.

Journal: International Journal of Oncology

Article Title: Butyrate supplementation regulates expression of chromosome segregation 1-like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer

doi: 10.3892/ijo.2022.5354

Figure Lengend Snippet: Different CSE1L expression levels in the colon cell lines. (A) Relative mRNA expression levels of CSE1L in CCD-18Co and FHC cells. (B) Relative mRNA expression levels of CSE1L in the CRC cell lines. (C) Relative mRNA expression levels of CSE1L in overconfluent Caco-2 cells. (D) Relative mRNA expression levels of c-Myc in overconfluent Caco-2 cells. (E) Protein expression level of CSE1L and c-Myc in overconfluent Caco-2 cells. (F) Relative mRNA expression levels of CSE1L in HCT116 cells with or without p53 expression. (G) Protein expression level of CSE1L in HCT116 cells with or without p53 expression. (H) Knockdown efficacy of p53 by mRNA level in HCT116 p53 +/+ cells. (I) Relative mRNA expression levels of CSE1L in HCT116 cells without or with p53 knockdown. (J) Protein expression levels of CSE1L in 5-FU-treated wild-type HCT116 cells. * P<0.05, ** P<0.01 and *** P<0.001. CRC, colorectal cancer; 5-FU, 5-fluouracil; shLuc, lentiviral construct targeting luciferase; shp53, lentiviral construct targeting p53; wt, wild-type; sh, short hairpin; CSE1L, chromo-some segregation 1-like protein.

Article Snippet: In addition, three human CRC cell lines (LS 174T, cat. no. CL-188; T84, cat. no. CCL-248; HCT116 p53 +/+ , cat. no. CCL-247; all from ATCC) expressing wild-type p53, two human CRC cell lines (SW480, cat. no. CCL-228; SW620, cat. no. CCL-227; both from ATCC) carrying the R273H and P309S double p53 mutation , in addition to two p53-null cell lines [Caco-2, cat. no. HTB-37, ATCC; HCT116 p53 −/− , a gift from Professor Bert Vogelstein (School of Medicine, Johns Hopkins University, Baltimore, USA)] ( , ), were used as tumorigenic cancer cells ( – ).

Techniques: Expressing, Knockdown, Construct, Luciferase

Effect of butyrate supplementation and CSE1L overexpression on the genetic distortion caused by p53 mutations in colorectal cancer. Butyrate supplementation downregulates expression of CSE1L in p53-mutated CRC cells to mitigate the maligancy of CRC. CSE1L, chromosome segregation 1-like protein.

Journal: International Journal of Oncology

Article Title: Butyrate supplementation regulates expression of chromosome segregation 1-like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer

doi: 10.3892/ijo.2022.5354

Figure Lengend Snippet: Effect of butyrate supplementation and CSE1L overexpression on the genetic distortion caused by p53 mutations in colorectal cancer. Butyrate supplementation downregulates expression of CSE1L in p53-mutated CRC cells to mitigate the maligancy of CRC. CSE1L, chromosome segregation 1-like protein.

Article Snippet: In addition, three human CRC cell lines (LS 174T, cat. no. CL-188; T84, cat. no. CCL-248; HCT116 p53 +/+ , cat. no. CCL-247; all from ATCC) expressing wild-type p53, two human CRC cell lines (SW480, cat. no. CCL-228; SW620, cat. no. CCL-227; both from ATCC) carrying the R273H and P309S double p53 mutation , in addition to two p53-null cell lines [Caco-2, cat. no. HTB-37, ATCC; HCT116 p53 −/− , a gift from Professor Bert Vogelstein (School of Medicine, Johns Hopkins University, Baltimore, USA)] ( , ), were used as tumorigenic cancer cells ( – ).

Techniques: Over Expression, Expressing